Prices are based on membership status. Once logged in, the correct registration rate will automatically populate. Physician, Scientist, Industry (Non-Exhibitor), PhD, Other $749 Resident/Student, Fellow, APP & Associate $575 Physician, Scientist, Industry (Non-Exhibitor), PhD, Other $799 Resident /Student, Fellow, APP & Associate
This phase 1b/2 nonrandomized clinical trial evaluates whether equecabtagene autoleucel can benefit patients with relapsed or refractory multiple myeloma and determines the overall response rate…
This is a one-day course which covers the underpinning mathematics of medical imaging, comprising image formation, image processing techniques, human visual perception and image display…
Nature Cancer – Trumpp and colleagues develop a method to obtain long-term circulating tumor cell-derived organoids from individuals with metastatic breast cancer and identify the…
Radiation therapy produced superior HRQOL outcomes and fewer toxicities vs endocrine therapy in older patients with stage I luminal-like breast cancer.
CMG901 showed a manageable safety profile and had promising antitumour activity in patients with advanced gastric or gastro-oesophageal junction cancer.
A paediatric haematologist has been made a Member of the Order of the British Empire (MBE) in this yearâs New Year Honours. Professor Ajay Vora,…
Harald Kittler, MD, Medical University of Vienna, Vienna, Austria, discusses using artificial intelligence (AI) to diagnose skin cancers. Dermoscopic and clinical images provide ideal image-based…
Nitin Jain, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, comments on the potential of combining atezolizumab, a humanized monoclonal antiâPD-L1 antibody,…
Endometrial cancer (EC) is increasing significantly among women in low- and middle-income countries (LMICs). EC detection may be improved by WID-qEC testing, a DNA methylation-based…
